Phase 1b Multi-Indication Study of the Antibody Drug Conjugate Anetumab Ravtansine in Patients with Mesothelin-Expressing Advanced or Recurrent Malignancies

被引：0
|
作者：
Adjei, A. [1 ]
Walter, A. [2 ]
Cupit, L. [3 ]
Siegel, J. [3 ]
Holynskyj, A. [3 ]
Childs, B. [3 ]
Elbi, C. [3 ]
机构：
[1] Mayo Clin, Rochester, NY USA
[2] Bayer AG, Berlin, Germany
[3] Bayer Healthcare Pharmaceut, Whippany, NJ USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.04-013
引用
收藏
页码：S1976 / S1976
页数：1
相关论文
共 50 条
  • [1] Phase 1b multi-indication study of the antibody drug conjugate anetumab ravtansine in patients with mesothelin-expressing advanced or recurrent malignancies
    Adjei, A. A.
    Walter, A.
    Cupit, L.
    Siegel, J.
    Holynskyj, A.
    Childs, B. H.
    Elbi, C.
    ANNALS OF ONCOLOGY, 2017, 28
  • [2] Phase 1b multi-indication study of the antibody drug conjugate anetumab ravtansine in patients with mesothelin-expressing advanced or recurrent malignancies.
    Adjei, Alex A.
    Bekaii-Saab, Tanios S.
    Berlin, Jordan
    Philip, Agop Philip
    Mercade, Teresa Macarulla
    Walter, Annette
    Cupit, Lisa
    Liu, Rong
    Fields, Scott Z.
    Holynskyj, Ariadna
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] An open-label, phase II study of intravenous anetumab ravtansine, an anti-mesothelin antibody drug conjugate, in pretreated mesothelin-expressing advanced pancreatic cancer.
    Chokshi, Saurin
    Hochster, Howard S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [4] Phase I Study of Anti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine
    Hassan, Raffit
    Bendell, Johanna C.
    Blumenschein, George, Jr.
    Kindler, Hedy Lee
    Moore, Kathleen N.
    Santin, Alessandro D.
    Seward, Shelly M.
    Nemunaitis, John
    Rajagopalan, Prabhu
    Walter, Annette
    Sarapa, Nenad
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S195 - S195
  • [5] Phase I study of anti-mesothelin antibody drug conjugate anetumab ravtansine (AR).
    Blumenschein, George R.
    Hassan, Raffit
    Moore, Kathleen N.
    Santin, Alessandro
    Kindler, Hedy L.
    Nemunaitis, John J.
    Seward, Shelly Marie
    Rajagopalan, Prabhu
    Walter, Annette
    Sarapa, Nenad
    Bendell, Johanna C.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Phase lb study of anetumab ravtansine in combination with pemetrexed and cisplatin in patients with mesothelin-expressing epithelial mesothelioma or nonsquamous non-small cell lung cancer
    Hassan, Raffit
    Wang, Ding
    Wrangle, John
    Thomas, Anish
    Byars, Angus
    Asschert, Lianne
    Atienza, Rolando
    Rajagopalan, Prabhu
    Walter, Annette
    Zhang, Jun
    Sarapa, Nenad
    Kindler, Hedy
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [7] First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors
    Hassan, Raffit
    Blumenschein, George R., Jr.
    Moore, Kathleen N.
    Santin, Alessandro D.
    Kindler, Hedy L.
    Nemunaitis, John J.
    Seward, Shelly M.
    Thomas, Anish
    Kim, Stella K.
    Rajagopalan, Prabhu
    Walter, Annette O.
    Laurent, Dirk
    Childs, Barrett H.
    Sarapa, Nenad
    Elbi, Cem
    Bendell, Johanna C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (16) : 1824 - +
  • [8] A phase 1b study of oral rapamycin (sirolimus) in patients with advanced malignancies
    Ratain, M. J.
    Napoli, K. L.
    Moshier, K. Knightley
    Jiang, X.
    Fleming, G. F.
    Gajewski, T. F.
    Jacobsen, E.
    Cohen, E. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Safety and activity of anti-mesothelin antibody-drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study
    Santin, Alessandro D.
    Vergote, Ignace
    Gonzalez-Martin, Antonio
    Moore, Kathleen
    Oaknin, Ana
    Romero, Ignacio
    Diab, Sami
    Copeland, Larry J.
    Monk, Bradley J.
    Coleman, Robert L.
    Herzog, Thomas J.
    Siegel, Jonathan
    Kasten, Linda
    Schlicker, Andreas
    Schulz, Anke
    Kochert, Karl
    Walter, Annette O.
    Childs, Barrett H.
    Elbi, Cem
    Bulat, Iurie
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (04) : 562 - 570
  • [10] A B7H3-targeting antibody-drug conjugate in advanced solid tumors: a phase 1/1b trial
    Ma, Yuxiang
    Yang, Yunpeng
    Huang, Yan
    Fang, Wenfeng
    Xue, Jinhui
    Meng, Xiangjiao
    Fan, Yun
    Fu, Siqing
    Wu, Lin
    Zheng, Yulong
    Liu, Jian
    Liu, Zhihua
    Zhuang, Wu
    Rosen, Seth
    Qu, Song
    Li, Bihui
    Li, Mingjun
    Zhao, Yanqiu
    Yang, Shujun
    Ji, Yinghua
    Sommerhalder, David
    Luo, Suxia
    Yang, Kunyu
    Li, Jingao
    Lv, Dongqing
    Zhang, Peng
    Zhao, Yuanyuan
    Hong, Shaodong
    Zhang, Yang
    Zhao, Shen
    Chin, Steve
    Zhang, Xian
    Lian, Wei
    Cai, Jiaqiang
    Xue, Tongtong
    Zhang, Li
    Zhao, Hongyun
    NATURE MEDICINE, 2025,
12345